DBV Technologies Joins Euronext Tech Leaders Index

DBV Technologies (Euronext: DBV, Nasdaq: DBVT), a clinical-stage biopharmaceutical company, has announced its inclusion in the Euronext Tech Leaders index, effective from June 22, 2026. The Euronext Tech Leaders index highlights high-growth European companies in fields such as software, biotech, fintech, and cleantech. This recognition places DBV Technologies among over 100 innovative companies across European markets such as Paris, Amsterdam, and Milan.

CEO Daniel Tassé expressed the company's honor in being recognized alongside Europe's leading innovators. He believes this recognition underscores their advancements in the VIASKIN® Peanut Patch, a potential treatment for peanut allergy in children. This inclusion is expected to enhance awareness of DBV's mission and progress.